Sequences

Sample result

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

GLP-1, a diabetes hormone

Protein → Patent proteins · Automatic (Smith-Waterman)

Download as Excel

Every list and the search record, one sheet each.

Query
GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
Set
Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran
2026-11-12
Found
5,000 sequences, 3,061 publications, 1,851 families

Charts

Identity against coverage

5,000 hits by identity and query coverage. 5,000 with a date.

Has a date707075758080858590909595100100Identity (%)Query coverage (%)
Show table
Hits by identity
BandHas a dateAll
100%553553
95 to 99.9%992992
90 to 94.9%2,6382,638
80 to 89.9%814814
70 to 79.9%33
Hits by query coverage
BandHas a dateAll
100%3,6063,606
95 to 99.9%876876
90 to 94.9%483483
80 to 89.9%3535

Hits by year

3,061 publications by year of first publication, 1990 to 2026.

Has a datePublications01002003001990199319961999200220052008201120142017202020232026
Show table
Publications by year of first publication
YearHas a dateAll
199022
199222
199311
199411
199511
199633
199722
199822
19991111
20001313
20012020
20023737
20033333
20043737
20055454
20066262
20077777
20088181
2009107107
2010101101
2011110110
2012121121
2013123123
2014135135
2015142142
2016144144
2017157157
2018149149
2019150150
2020156156
2021183183
2022161161
2023175175
2024181181
2025231231
20269696

Where hits align on the query

The top 20 hits on GLP-1, a query of 31 amino acids: 20 cover the whole query, none differs from it.

Aligned partDiffers from the queryGLP-1 · 31 amino acids151015202531HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRGAAA55132.1A31422.1AAB11984.1DI506186DI527435AAB11995.1AAE02614.1DI540976DI521338DI502216DJ789879DI520483AAE49428.1AAE49430.1AAE49429.1AAE49432.1DI501808AAY78103.1BD613525BD613528
Show table
The top 20 hits on GLP-1, positions on the query
HitQuery fromQuery toIdentityDiffers atGaps atX at
AAA55132.1131100.0%NoneNoneNone
A31422.1131100.0%NoneNoneNone
AAB11984.1131100.0%NoneNoneNone
DI506186131100.0%NoneNoneNone
DI527435131100.0%NoneNoneNone
AAB11995.1131100.0%NoneNoneNone
AAE02614.1131100.0%NoneNoneNone
DI540976131100.0%NoneNoneNone
DI521338131100.0%NoneNoneNone
DI502216131100.0%NoneNoneNone
DJ789879131100.0%NoneNoneNone
DI520483131100.0%NoneNoneNone
AAE49428.1131100.0%NoneNoneNone
AAE49430.1131100.0%NoneNoneNone
AAE49429.1131100.0%NoneNoneNone
AAE49432.1131100.0%NoneNoneNone
DI501808131100.0%NoneNoneNone
AAY78103.1131100.0%NoneNoneNone
BD613525131100.0%NoneNoneNone
BD613528131100.0%NoneNoneNone

Patents 3.1K

Columns
Tick the columns each row shows, then choose Show. The arrows move a column.

3,061 publications from 692 applicants, 83 with no applicant, match these filters.

Amylin Pharmaceuticals, Inc. 78 publications, continued

  1. US 6902744-A2005-06-07

    Exendin agonist formulations and methods of administration thereof

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  2. JP 2006514035-A2006-04-27

    PREVENTION AND TREATMENT OF CARDIAC ARRHYTHMIAS

    AMYLIN PHARMACEUTICALS INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  3. US 7157555-A2007-01-02

    Exendin agonist compounds

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  4. Exendin for treating diabetes and reducing body weight

    AMYLIN PHARMACEUTICALS, INC. (US)

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  5. US 7220721-A2007-05-22

    Exendin agonist peptides

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  6. US 7223725-A2007-05-29

    Exendin agonist compounds

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  7. WO 2008005527-A2008-01-10

    Glucagon-like peptides and uses thereof

    Amylin Pharmaceuticals, Inc. (US)

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  8. EP 1938830-A12008-07-02

    Novel exendin agonist compounds

    AMYLIN PHARMACEUTICALS, INC. (US)

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  9. EP 1938831-A12008-07-02

    Novel exendin agonist compounds

    AMYLIN PHARMACEUTICALS, INC. (US)

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  10. EP 1941900-A12008-07-09

    Novel exendin agonist compounds

    AMYLIN PHARMACEUTICALS, INC. (US)

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  11. JP 2008530130-A2008-08-07

    GIP ANALOG AND HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES

    AMYLIN PHARMACEUTICALS INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  12. US 7442680-A2008-10-28

    Inotropic and diuretic effects of GLP-1 and GLP-1 agonists

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  13. JP 2010500996-A2010-01-14

    DPP-IV RESISTANT GIP HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES

    AMYLIN PHARMACEUTICALS INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  14. US 7696161-B22010-04-13

    Exendin agonist compounds

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  15. US 7790681-B22010-09-07

    Treatment of cardiac arrhythmias with GLP-1 receptor ligands

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  16. EP 2303313-A22011-04-06

    EXENDINS TO LOWER CHOLESTROL AND TRIGLYCERIDES

    AMYLIN PHARMACEUTICALS INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  17. US 7928065-B22011-04-19

    Methods of treatment using exendin peptides or GLP-1 peptides

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  18. EP 2347762-A12011-07-27

    Exendin for treating diabetes and reducing body weight

    AMYLIN PHARMACEUTICALS INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  19. EP 2392595-A12011-12-07

    GIP analog and hybrid polypeptides with selectable properties

    AMYLIN PHARMACEUTICALS INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  20. US 8263545-B22012-09-11

    GIP analog and hybrid polypeptides with selectable properties

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  21. US 8263550-B22012-09-11

    Exendin agonist compounds

    Amylin Pharmaceuticals, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  22. US 8329648-B22012-12-11

    Methods for treating diabetes and reducing body weight

    Amylin Pharmaceuticals, LLC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  23. US 8404637-B22013-03-26

    GIP analog and hybrid polypeptides with selectable properties

    Amylin Pharmaceuticals, LLC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  24. JP 2014058528-A2014-04-03

    DPP-IV RESISTANT GIP HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES

    AMYLIN PHARMACEUTICALS INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  25. EP 2841090-A12015-03-04

    SITE-SPECIFIC ENZYMATIC MODIFICATION OF EXENDINS AND ANALOGS THEREOF

    AMYLIN PHARMACEUTICALS LLC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  26. EP 3524261-A12019-08-14

    EXENDIN FOR TREATING DIABETES AND REDUCING BODY WEIGHT

    AMYLIN PHARMACEUTICALS LLC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  27. EP 1419783-A22004-05-19

    Use of a composition comprising an exendin or a compound derived therefrom and a pharmaceutical carrier

    AMYLIN PHARMACEUTICALS, INC. (US)

    Query Match 95.7%Identity 96.8%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             ||||||||||||||||||| |||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAALEFIAWLVKGRG 31
    

    30 of 31 identical, no gaps.

  28. Hybrid polypeptides with selectable properties

    AMYLIN PHARMACEUTICALS, INC. (US)

    Query Match 93.8%Identity 96.7%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             || |||||||||||||||| |||||||||||
    Hit    1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 31
    

    29 of 31 identical, no gaps.

  29. JP 2007525495-A2007-09-06

    HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES

    AMYLIN PHARMACEUTICALS INC

    Query Match 93.8%Identity 96.7%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             || |||||||||||||||| |||||||||||
    Hit    1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 31
    

    29 of 31 identical, no gaps.

  30. JP 2011219488-A2011-11-04

    HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES

    AMYLIN PHARMACEUTICALS INC

    Query Match 93.8%Identity 96.7%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             || |||||||||||||||| |||||||||||
    Hit    1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 31
    

    29 of 31 identical, no gaps.

  31. JP 2011246468-A2011-12-08

    HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES

    AMYLIN PHARMACEUTICALS INC

    Query Match 93.8%Identity 96.7%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             || |||||||||||||||| |||||||||||
    Hit    1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 31
    

    29 of 31 identical, no gaps.

  32. US 8076288-B22011-12-13

    Hybrid polypeptides having glucose lowering activity

    Amylin Pharmaceuticals, Inc.

    Query Match 93.8%Identity 96.7%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             || |||||||||||||||| |||||||||||
    Hit    1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 31
    

    29 of 31 identical, no gaps.

  33. EP 2417980-A12012-02-15

    Hybrid polypeptides with selectable properties

    AMYLIN PHARMACEUTICALS INC

    Query Match 93.8%Identity 96.7%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             || |||||||||||||||| |||||||||||
    Hit    1 HAQGTFTSDVSSYLEGQAALEFIAWLVKGRG 31
    

    29 of 31 identical, no gaps.

  34. JP 2002509078-A2002-03-26

    Inotropic and diuretic effects of exendin and GLP-1

    AMYLIN PHARMACEUTICALS INC

    Query Match 93.2%Identity 100.0%

    Best alignment

    Query 1 to 29, hit 1 to 29. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
             |||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKG 29
    

    29 of 29 identical, no gaps.

  35. HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES

    Amylin Pharmaceuticals, LLC.

    Query Match 93.2%Identity 96.7%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             || |||||||||||||||| |||||||||||
    Hit    1 HAKGTFTSDVSSYLEGQAALEFIAWLVKGRG 31
    

    29 of 31 identical, no gaps.

BIONEBRASKA, INC. (US) 12 publications

  1. WO 0066138-A22000-11-09

    Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue

    BIONEBRASKA, INC. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  2. WO 0066142-A22000-11-09

    Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain

    BIONEBRASKA, INC. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  3. WO 0077039-A22000-12-21

    Glp-1 as a diagnostic test to determine _g(b)-cell function and the presence of the condition of igt and type-ii diabetes

    BIONEBRASKA, INC. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  4. WO 0187322-A22001-11-22

    Peptide pharmaceutical formulations

    BIONEBRASKA, INC. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  5. WO 0189554-A22001-11-29

    Treatment of acute coronary syndrome with glp-1

    BIONEBRASKA, INC. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  6. US 6344180-A2002-02-05

    GLP-1 as a diagnostic test to determine .beta.-cell function and the presence of the condition of IGT and type II diabetes

    BioNebraska, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  7. US 6429197-A2002-08-06

    Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain

    Bionebraska, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  8. JP 2002543142-A2002-12-17

    Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue

    BIONEBRASKA INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  9. JP 2002543145-A2002-12-17

    Metabolism intervention using GLP-1 or its biologically-active analog for improving brain function in ischemia and reperfusion injury

    BIONEBRASKA INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  10. JP 2003502344-A2003-01-21

    GLP-1 as diagnostic and examination reagent for judging beta-cell function and the presence of IGT diseases and type II diabetes

    BIONEBRASKA INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  11. JP 2002529101-A2002-09-10

    Enzymatic amidation of peptides

    BIONEBRASKA INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  12. US 6461834-A2002-10-08

    Clostripain catalyzed amidation of peptides

    Bionebraska, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

Conjuchem, Inc. 23 publications

  1. WO 0069900-A22000-11-23

    Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components

    Conjuchem, Inc. (CA)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  2. WO 0069911-A12000-11-23

    Long lasting insulinotropic peptides

    Conjuchem, Inc. (CA)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  3. US 6329336-A2001-12-11

    Long lasting insulinotropic peptides

    Conjuchem, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.